This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: **Innovator Pierre-Francois Berne: Pioneering Cancer Treatment through Antibody Research**
Introduction
Pierre-Francois Berne, an accomplished inventor based in Paris, France, has made significant contributions to the field of biomedical innovation. With a focus on developing therapeutic solutions, Berne has been awarded three patents throughout his career. His innovative work primarily involves the study of antibodies and their applications in cancer treatment.
Latest Patents
Berne's latest patents include groundbreaking findings on Anti-CEACAM5 antibodies and their uses. These patents describe antibodies that specifically bind to human CEACAM5 proteins, which play a crucial role in cancer biology. Additionally, Berne's work includes the development of isolated nucleic acids, vectors, and host cells that contain sequences encoding these antibodies. The patents also outline the creation of immunoconjugates that link the antibodies to growth-inhibitory agents, providing new pathways for pharmaceutical compositions designed to treat cancer or serve diagnostic purposes.
Career Highlights
Pierre-Francois Berne is currently affiliated with Sanofi, a global healthcare leader known for its innovative approach to pharmaceuticals. His expertise lies in the intersection of biotechnology and therapeutic development, particularly in the creation of targeted cancer treatments. Throughout his career at Sanofi, Berne has continually pushed the boundaries of biomedical science, resulting in valuable patents that can transform cancer care.
Collaborations
Working alongside notable colleagues such as Francis Blanche and Hervé Bouchard, Berne has fostered a collaborative environment that encourages innovative research. These partnerships have been instrumental in advancing the development of therapeutic antibodies and enhancing the overall impact of their findings in the medical field.
Conclusion
In summary, Pierre-Francois Berne is a prominent inventor whose work in the field of antibody research has the potential to change cancer treatment paradigms. With three patents under his belt and ongoing collaborations at Sanofi, Berne remains at the forefront of biomedical innovation, devoted to improving patient outcomes and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile